Abbott: Leerink Partners cuts target price to $106 from $109
ABT•Leerink Partners cut its target price for Abbott to $106 from $109.
Related News
Electra Therapeutics initiated with overweight rating by J.P. Morgan; price target $36
ETRA•
U.S. Bancorp survey finds 78% of industrial, manufacturing finance leaders expect M&A activity to rise
USB•
MoffettNathanson raises Meta target price by $155 to $895
META•
Thermo Fisher Scientific: JPMorgan raises target price to $820 from $760
TMO•
Barclays raises Nike target price to $45 from $37
NKE•